Dex@ldh/met

Dex@ldh/met has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest story, Oct 8, 2026: “Mitochondrial transfer restored bone structure in animals”.

Intervention

1 paper studies it1 findingUpdated

  • 1 lab in 1 country
  • Funders: National Key Research and Development Program of China and 1 more
  • Animals1

What did studies of Dex@ldh/met find?

1

Studies of Dex@ldh/met measured 1 outcome; the most studied are mitochondrial fission and fusion (1 study).

Mitochondrial fission and fusion

downin cells1

1 study
  1. Dex@ldh/met decreases mitochondrial fission and fusion in cells.

    “This coordinated regulation enabled suppression of dynamin‐related protein 1 (DRP1) mediated mitochondrial fission”

    Cellslayered double hydroxide nanohybrid incorporating dexamethasone and metforminbone mesenchymal stem cell

    Mitochondrial transfer restored bone structure in animals

    Advanced Functional Materials

More on Mitochondrial fission and fusion

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 01 paper in 12 months
Advanced Functional Materials

Mitochondrial transfer restored bone structure in animals

In an osteoporosis animal model, mitochondria from treated stem cells promoted blood vessel formation and restored the structure of spongy bone.In an osteoporosis animal model, mitochondria from treated stem cells promoted blood vessel formation and restored the structure of spongy bone.

Experiments in animalsBones and joints